11:19 AM EST, 11/06/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.1% to 1,589.29 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion ( EVAX ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 5.7% and 4.6% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria ( BBVA ) and biopharmaceutical company argenx (ARGX), which were up 2.9% and 2.7% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and software firm SAP (SAP), which dropped 3.5% and 3.3% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical company Grifols ( GRFS ) , which lost 3% and 2.7% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and pharmaceutical company AstraZeneca ( AZN ) , which advanced 4.4% and 3.3% respectively. They were followed by biopharmaceutical company Amarin ( AMRN ) and pharmaceutical company Silence Therapeutics ( SLN ) , which increased 2% and 2.6% respectively.

The decliners from the UK and Ireland were led by medical device maker Smith & Nephew ( SNN ) and alcoholic beverage company Diageo ( DEO ) , which fell 12% and 6.5% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and educational publisher Pearson (PSO), which were down 4.2% and 3.4% respectively.